Latest for Hypoparathyroidism
See all trialsThe week in rare diseaseEach date is the day a change was posted. Open an item to see where things stand now.
- Who can joinWho can join changed for Efficacy, Safety, and Tolerability of Encaleret in Participants With Chronic… (Phase 3)ClinicalTrials.gov
- Label changeThe FDA approved a label update for YorvipathFDA
More about Hypoparathyroidism
PTH then raises calcium by pulling it from bones, increasing kidney reabsorption, and activating vitamin D to boost intestinal calcium absorption. When PTH is absent or insufficient, blood calcium drops and phosphorus rises, creating a state of neuromuscular irritability that can range from mild tingling to life-threatening seizures and cardiac arrhythmias.
Keep reading about Hypoparathyroidism
For decades, treatment was limited to high-dose calcium and active vitamin D supplements, which manage symptoms but don't restore normal physiology and carry risks of kidney damage from excess calcium in the urine. In August 2024, the FDA approved Yorvipath (palopegteriparatide), developed by Ascendis Pharma, for hypoparathyroidism in adults. It is now the only PTH replacement therapy sold in the US.
Yorvipath is a once-daily subcutaneous injection that releases a PTH analog to restore more normal calcium regulation. An earlier PTH replacement, Natpara (rhPTH[1-84]), was recalled in 2019 due to rubber particulate contamination and was ultimately discontinued by Takeda at the end of 2024.
What are the symptoms of Hypoparathyroidism?
These are common symptoms of Hypoparathyroidism, and how strong they are varies from person to person.
- Tingling and numbness around the mouth, hands, and feet (paresthesias)
- Muscle cramps and spasms, particularly in the hands and feet (carpopedal spasms)
- Tetany with uncontrollable muscle twitching and cramping
- Seizures in more severe or untreated cases
- Laryngospasm (spasm of the voice box) causing breathing difficulty
- Cardiac arrhythmias from prolonged low calcium levels
- Chronic fatigue and generalized weakness
- Anxiety, depression, and difficulty concentrating (brain fog)
- Brittle nails, dry skin, and coarse hair
- Kidney stones and calcium deposits in soft tissues over time
Who gets Hypoparathyroidism?
Hypoparathyroidism can occur at any age. The majority of cases result from surgical complications during thyroidectomy, parathyroidectomy, or other neck procedures. The remaining cases are genetic (including DiGeorge syndrome from 22q11.2 deletion), autoimmune, or idiopathic.
It affects males and females, though postsurgical cases are more common in women. Genetic forms can follow autosomal dominant or autosomal recessive inheritance patterns.
Next steps: find trials you might fitsee approved treatmentsget help payingget alerts
Which medicines are FDA-approved for Hypoparathyroidism?
There are currently 3 FDA-approved medications for Hypoparathyroidism.
Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.
How to get help paying for Hypoparathyroidism treatment
Charity funds and drugmaker programs for Hypoparathyroidism, checked at the source.
- From a charity · The Assistance FundHypoparathyroidism fundOpen
Pays for: Copays, coinsurance, deductibles and other health-related expenses.
Every program and fund for Hypoparathyroidism, by insurance →
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
Genetic testing for Hypoparathyroidism
Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.
Finding labs...
Trusted Hypoparathyroidism resources
Reputable organizations and medical references for learning more about Hypoparathyroidism, including disease registries, foundation resources, and clinical guidelines.